Publication | Closed Access

The Absolute Oral Bioavailability and??Population-Based Pharmacokinetic Modelling of a Novel Dipeptidylpeptidase-IV Inhibitor, Vildagliptin, in Healthy Volunteers

Pharmacokinetic ModelingNovel Dipeptidylpeptidase-iv InhibitorHealthy VolunteersPharmacologyAbsolute Oral BioavailabilityPharmacotherapyMedicinePhysiologically-based Pharmacokinetic ModelingPharmacokineticsDrug DiscoveryDrug Resistance